Form3, the UK-based cloud-native account-to-account platform, has announced a new investor, British Patient Capital.
Alongside existing strategic and financial investors including Visa, Form3 has now raised a total of $60m in Series C extension funding to continue its growth journey.
This fresh funding will enable Form3 to develop new products and services to help support exponential growth in key markets such as the UK, Europe and the US.
Benyam Hagos, chief financial officer of Form3 said: “British Patient Capital’s investment enables Form3 to continue to deliver mission-critical infrastructure technology for the world’s most established banks and financial institutions.”
Tom Haywood, managing director, direct investments, British Patient Capital, said: “Form3 has built a leading solution for a challenge that banks worldwide are facing: how to transition to a modern, future-proof payments infrastructure. We are delighted to support them as they take the next steps in their growth journey.”
Founded in 2016, Form3 wanted to “revolutionise” the world of payment processing and disrupt the traditional payment infrastructure model, with an always on, cloud-native, Payments-as-a-Service (PaaS) platform. Today, Form3 claims it is trusted by some of the UK’s and Europe’s biggest Tier1 banks and growing fintechs to handle their payments architecture.
